5-aminosalicylic acid

PheWeb

RX_A07EC02

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A07EC02

7818

Check pre-conditions, main-only, mode, ICD version None

6067

Check minimum number of events

Min. number of events 3

6067

Include endpoints None

6067

RX_A07EC02

Extra metadata

First used in FinnGen datafreeze DF4

Similar endpoints

↥

List of similar endpoints to 5-aminosalicylic acid based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	5892	3183	2709
Unadjusted prevalence (%)	1.91	1.83	2.01
Mean age at first event (years)	43.14	41.54	45.01

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.39 [0.99, 1.97]	6.1e-2	280
15 years	0.01	0.93 [0.65, 1.32]	6.8e-1	128
5 years	0.00	2.09 [1.50, 2.92]	1.5e-5	78
1 year	0.00	1.56 [0.82, 2.96]	1.8e-1	11

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_A07EC02 – 5-aminosalicylic acid
GWS hits:

Survival analyses between endpoints

↥

Plot

before 5-aminosalicylic acid
after 5-aminosalicylic acid

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after 5-aminosalicylic acid

↥